Clinical Trial Update: Gemcitabine in NK/T Cell Lymphoma

View source ↗

Summary

Completed clinical trial evaluating gemcitabine in Extranodal natural killer/T-cell lymphoma, nasal type.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Samsung Medical Center | Conditions: NK/T Cell Lymphoma | Status: COMPLETED